News for 'Post Sun Pharma'

Sensex sheds 338 pts dragged by losses in index majors

Sensex sheds 338 pts dragged by losses in index majors

Rediff.com20 May 2021

ONGC was the top loser in the Sensex pack, shedding around 3 per cent, followed by Sun Pharma, PowerGrid, Axis Bank, HDFC Bank, Bharti Airtel and Kotak Bank. NSE Nifty declined 124.10 points to 14,906.05.

Markets end lower, post biggest monthly drop since Nov 2011

Markets end lower, post biggest monthly drop since Nov 2011

Rediff.com31 Aug 2015

Sensex remained volatile through the day.

'Worse for heart attacks': British Indian doc flags issues with Covishield

'Worse for heart attacks': British Indian doc flags issues with Covishield

Rediff.com7 Feb 2023

Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".

Sensex rallies 546.41 pts to end at all-time high of 54,370

Sensex rallies 546.41 pts to end at all-time high of 54,370

Rediff.com4 Aug 2021

HDFC was the top gainer in the Sensex pack, surging around 5 per cent, followed by Kotak Bank, ICICI Bank, SBI, HDFC Bank and Axis Bank. On the other hand, Titan, Nestle India, Ultratech Cement and Sun Pharma were among the laggards. NSE Nifty surged 128.05 points to its all-time peak of 16,246.85.

Exports post first rise in 7 months, grow by 2.91% in Feb

Exports post first rise in 7 months, grow by 2.91% in Feb

Rediff.com13 Mar 2020

Trade deficit marginally widened to $9.85 billion as against $9.72 billion in February 2019.

IT funds pip consumer, pharma on 1-year returns

IT funds pip consumer, pharma on 1-year returns

Rediff.com1 Aug 2013

managers said the weaker rupee, which has driven up shares of technology companies, has helped the fund fetch better returns.

Sensex rallies over 450 pts on last trading day of 2021

Sensex rallies over 450 pts on last trading day of 2021

Rediff.com31 Dec 2021

Titan was the top gainer in the Sensex pack, rising 3.5 per cent, followed by Kotak Bank, SBI, Maruti Suzuki, Bajaj Finance, HUL, Axis Bank and Sun Pharma. On the other hand, NTPC, Tech Mahindra, PowerGrid and Infosys were the laggards.

Pharma tops in patent suits

Pharma tops in patent suits

Rediff.com18 Jan 2010

Pharmaceutical patents are just over a fourth of all patents granted in the country, but domestic drug makers account for almost all post-grant patent opposition filed, official data reveals.

Exports rise 16.78%; trade deficit at record $25.63 bn

Exports rise 16.78%; trade deficit at record $25.63 bn

Rediff.com4 Jul 2022

India's merchandise exports in June rose by 16.78 per cent year-on-year to $37.94 billion while the trade deficit ballooned to a record $25.63 billion on account of a steep increase in gold and crude oil imports, according to the government's preliminary data released on Monday. The export growth in June moderated from 20.55 per cent in May and 48.34 per cent in June 2021. During the month under review, exports of engineering, pharmaceutical and plastic products recorded negative growth.

Sensex jumps 222 pts to fresh closing high; RIL rallies over 4%

Sensex jumps 222 pts to fresh closing high; RIL rallies over 4%

Rediff.com11 Feb 2021

Among the gainers, RIL was followed by Sun Pharma, PowerGrid, Bajaj Finance, Nestle India and HCL Tech. On the other hand, Titan, L&T, ONGC, HDFC Bank and ITC were among the laggards.

Sensex, Nifty jump over 1%; post third weekly gain

Sensex, Nifty jump over 1%; post third weekly gain

Rediff.com18 Mar 2016

Rise in crude oil price and rally in global equities aided the sentiment

Investors' wealth plummets over Rs 6.80 lakh cr in 3 days

Investors' wealth plummets over Rs 6.80 lakh cr in 3 days

Rediff.com20 Jan 2022

Investors' wealth has eroded by over Rs 680,441 crore in three days of market fall amid weak global trends and muted domestic sentiments. Extending its losses for the third straight day, BSE benchmark Sensex on Thursday finished below the 60,000-level, weighed by hectic selling in IT, energy and finance stocks amid a sell-off in European equities. The index has lost 1,844.29 points in three sessions.

MBA, MS in Pharma

MBA, MS in Pharma

Rediff.com10 Mar 2008

National Institute of Pharmaceutical Education and Research (NIPER)'s admission to M.S. (Pharm), M.Pharm, M.Tech (Pharm) and M.B.A (Pharm) programs for 2008-09.

Mutual funds take a hit post note ban

Mutual funds take a hit post note ban

Rediff.com1 Dec 2016

The average fall in 15 most-invested stocks by equity MFs was 5.7 per cent. Chandan Kishore Kant reports

India's personal data protection bill may threaten innovation, growth: USTR

India's personal data protection bill may threaten innovation, growth: USTR

Rediff.com29 Apr 2022

The US on Thursday raised concerns over India's Personal Data Protection (PDP) Bill and draft non-personal data governance framework, claiming these could potentially threaten innovation and economic growth. In its latest 'Special 301' Report, the US Trade Representative (USTR) kept India on the priority watch list, maintaining the country remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP). In December 2021, a joint parliamentary committee released a report recommending changes to the PDP Bill, 2019, that could undermine important IP protections in India.

At 28L, average CTC at ISB up by 8%

At 28L, average CTC at ISB up by 8%

Rediff.com24 Mar 2021

Of the 1,145 offers made this year, consulting firms made up 34 per cent, followed by banking, financial services and insurance, pharma/healthcare, IT/ITeS and FMCG/retail.

Monday Market Crash: Advice For Investors

Monday Market Crash: Advice For Investors

Rediff.com14 Mar 2023

'Such big falls are quite frequent these days, so do not try to time this market.' 'Use big dips to accumulate quality stocks.'

Investors bet big on cyclicals as economic recovery gathers pace

Investors bet big on cyclicals as economic recovery gathers pace

Rediff.com18 Feb 2021

sharper-than-expected economic recovery back home, analysts say, can fuel a further rally in domestic cyclicals, industrials, and financials as global central banks continue with their easy money policy.

Sensex slides by 135 points as markets fall for 6th straight day

Sensex slides by 135 points as markets fall for 6th straight day

Rediff.com17 Jun 2022

Market benchmarks gave up intra-day gains to close in the red for the sixth session on the trot on Friday, capping a bruising week which saw a massive dash for safety amid rate hikes by global central banks and fears of slowing growth.

Markets rally on robust buying; post best week in five

Markets rally on robust buying; post best week in five

Rediff.com11 May 2018

Both the indices ended at their highest levels since February 1.

Sensex, Nifty advance on gains in IT, FMCG stocks

Sensex, Nifty advance on gains in IT, FMCG stocks

Rediff.com15 Nov 2021

Stock market barometers Sensex and Nifty ended marginally higher on Monday as rise in wholesale inflation capped early gains despite a positive trend in global markets. The 30-share index settled 32.02 points or 0.05 per cent higher at 60,718.71 with half of its constituents ending in green. The broad based Nifty edged up 6.70 points or 0.04 per cent to close at 18,109.45.

Managers for the pharma industry

Managers for the pharma industry

Rediff.com11 Jan 2005

The SIES College of Management Studies invites applications for two of its flagship programmes.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

10 stocks that FPIs bought and sold the most

10 stocks that FPIs bought and sold the most

Rediff.com12 May 2022

The FPI holding in India's top 100 companies, which are part of the Nifty 100 index, declined to 24.23 per cent on average at the end of March this year, from a high of 27.5 per cent at the end of March 2021. This is the lowest FPI holdings in India's top listed companies in at least three years. A general sell-off by FPIs has weighed on stock prices and the benchmark S&P BSE Sensex is down 8.5 per cent, from its 52-week high made in October 2021. Most analysts expect FPI flows to remain weak in FY23 as well, given rising bond yields in the US and an expected earnings slowdown in India due to high inflation and commodity prices.

IPOs listed since Sept down 20% from peak

IPOs listed since Sept down 20% from peak

Rediff.com30 Mar 2021

'Whenever markets rally, the IPO pricing gets aligned to the prevailing market conditions.'

Hiring at all-time high in July: Report

Hiring at all-time high in July: Report

Rediff.com6 Aug 2021

Hiring activity in the country touched an all-time high in July, witnessing a 11 per cent sequential increase, indicating a strong revival of economic growth and a recovery of business from the impact of COVID-19, a report said on Friday. With 2,625 job postings, hiring trends grew 11 per cent in July compared with 2,359 postings in June, the highest it has ever been, including the pre-COVID-19 timeline, according to the report by Naukri JobSpeak. The Indian job market has witnessed sequential growth for the second month in a row, with a 15 per cent rise in June, after the pandemic-linked decline in April and May, it stated.

MF GURU: 'You're taking aggressive risks'

MF GURU: 'You're taking aggressive risks'

Rediff.com26 Sep 2022

Nikunj Saraf, Vice President Choice Wealth, answers your queries.

Sensex, Nifty post best gain in a month

Sensex, Nifty post best gain in a month

Rediff.com30 Mar 2016

Broader markets are outperforming the benchmark indices- BSE Midcap and Smallcap indices are up 0.8%-1%.

Reliance Retail acquires sole control of Just Dial

Reliance Retail acquires sole control of Just Dial

Rediff.com2 Sep 2021

Billionaire Mukesh Ambani-led Reliance Retail on Thursday said it has acquired sole control of 25-year-old search and discovery firm Just Dial. The firm's subsidiary Reliance Retail Ventures Ltd had in July announced a deal to buy a controlling stake in Just Dial for Rs 3,497 crore. Further to that announcement, "RRVL has now taken sole control of Just Dial Ltd in accordance with the SEBI Takeover Regulations with effect from September 1, 2021."

Glenmark Pharma net dips 31 percent

Glenmark Pharma net dips 31 percent

Rediff.com30 Oct 2009

A sharp increase in interest costs has caused Glenmark Pharmaceuticals to post a consolidated net profit of Rs 80.9 crore for the second quarter, 31 percent lower than the Rs 117.3 crore for the previous corresponding quarter.

Market Fall: What Investors Should Do

Market Fall: What Investors Should Do

Rediff.com27 Dec 2022

'Investors should continue to invest because you are looking at the long-term; in the next four to five years, we are bound to outperform (the rest of the world equity markets).'

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

Rediff.com28 Dec 2021

The emergency use of the drug will be for adult COVID-19 patients with SpO2 93 percent and who have a high risk of progression of the disease including hospitalisation or death subject to certain conditions

Sensex gains on Fed rally; posts best week since mid-June

Sensex gains on Fed rally; posts best week since mid-June

Rediff.com9 Oct 2015

Sensex, Nifty put up a good show in closing trade.

Mid, small-cap stocks see post-Budget blues

Mid, small-cap stocks see post-Budget blues

Rediff.com28 Jul 2014

Bluechips underperform in recent rally.

How markets will fare post elections

How markets will fare post elections

Rediff.com11 Apr 2014

The markets tend to react six to eight months in advance

Manufacturing beats IT, pharma in returns

Manufacturing beats IT, pharma in returns

Rediff.com20 Nov 2007

Three manufacturing sectors (engineering and construction, industrial commodities and materials and commodities) created more value for its shareholders in last five years than IT or pharmaceutical companies. Engineering and construction companies, led by Larsen & Toubro and BHEL, posted a total shareholder return of 81 per cent in the last five years trailing March 31, 2007, the BCG-CII study showed.

IT, pharma sectors likely to be backbone of Telangana

IT, pharma sectors likely to be backbone of Telangana

Rediff.com21 Feb 2014

Global IT giants such as FaceBook, Google, IBM and Microsoft have a base in Hyderabad.

Sensex rebounds 172 pts to post surprise rally

Sensex rebounds 172 pts to post surprise rally

Rediff.com13 Jan 2016

Reliance Industries, Infosys and Tata Motors were the top contributors

Pharma stocks now on the radar

Pharma stocks now on the radar

Rediff.com15 Jan 2007

Pharmaceutical is one of the key theme for 2007 at brokerage houses such as Religare Securities, Angel Broking and Pranav Securities.

Sensex zooms 976 pts as financial stocks lift sentiments

Sensex zooms 976 pts as financial stocks lift sentiments

Rediff.com21 May 2021

HDFC Bank was the top gainer in the Sensex pack, rallying over 4 per cent, followed by SBI. IndusInd Bank, ICICI Bank, Axis Bank and HDFC were also among the gainers. NSE Nifty soared 269.25 points to 15,175.30.